AUXILIUM PHARAMCEUTICALS INC
AUXL
AUXL was delisted on the 29th of January, 2015.
0 hedge funds and large institutions have $0 invested in AUXILIUM PHARAMCEUTICALS INC in 2015 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $793K → $0 (-$793K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCS
Crosspoint Capital Strategies
Orinda,
California
|
-$8K |
AUXL Hedge Fund Activity: Q3 2015 in Review
0 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in AUXILIUM PHARAMCEUTICALS INC (AUXL) for Q3 2015, worth a combined $0 — down 100% from $793K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of AUXL and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Crosspoint Capital Strategies, exiting entirely with an estimated $8K sold.
- 0 institutional investors held AUXILIUM PHARAMCEUTICALS INC (AUXL) as of Q3 2015, down from 2 in Q2 2015.
- Funds reported $0 of AUXILIUM PHARAMCEUTICALS INC stock for Q3 2015, down 100% quarter-over-quarter.
- 0 funds opened new AUXILIUM PHARAMCEUTICALS INC positions in Q3 2015 and 1 closed out, a net change of -1 holder.
- The largest AUXILIUM PHARAMCEUTICALS INC seller in Q3 2015 was Crosspoint Capital Strategies, an estimated $8K sold.
Based on aggregated 13F filings for Q3 2015.